Black Diamond Therapeutics Funding: $194M Raised, Series C

Black Diamond Therapeutics is based in Cambridge. It has raised $194M in total funding. Latest round: Series C.

Black Diamond Therapeutics funding overview

Black Diamond Therapeutics is based in Cambridge. Black Diamond Therapeutics has raised $194M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in December 2019. The round record for Black Diamond Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include Boxer Capital, Wellington Management Company, BVF Partners L.P., Deerfield Management, Janus Henderson Investors, Casdin Capital and 9 others. 15 distinct backers are named across the disclosed rounds.

Black Diamond Therapeutics at a glance

Total raised
$194M
Latest round
Series C
Latest round date
December 2019
Headquarters
Cambridge
Notable investors
Boxer Capital, Wellington Management Company, BVF Partners L.P., Deerfield Management, Janus Henderson Investors, Casdin Capital, Logos Capital, Versant Ventures

Frequently asked about Black Diamond Therapeutics funding

How much has Black Diamond Therapeutics raised?
Black Diamond Therapeutics has raised $194M in total disclosed funding across the rounds on record.
Who has invested in Black Diamond Therapeutics?
Boxer Capital, Wellington Management Company, BVF Partners L.P., Deerfield Management, Janus Henderson Investors, Casdin Capital are named among the investors backing Black Diamond Therapeutics.
What was the latest Black Diamond Therapeutics funding round?
The most recent disclosed round is a Series C, announced in December 2019.
Where is Black Diamond Therapeutics based?
Black Diamond Therapeutics is based in Cambridge.
When did Black Diamond Therapeutics last raise?
The last disclosed Black Diamond Therapeutics round closed in December 2019 at Series C.

Black Diamond Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.

Companies related to Black Diamond Therapeutics (35)

Browse related funding lists (11)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades